Effects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled study
- PMID: 27142448
- PMCID: PMC4855797
- DOI: 10.1186/s12937-016-0168-7
Effects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled study
Abstract
Background: Green tea is a beverage with potential effects on cognitive dysfunction, as indicated by results of experimental studies. However, its effects in humans, especially at real-world (typical) consumption levels, are unclear.
Methods: A double-blind, randomized controlled study was conducted to assess the effects of green tea consumption on cognitive dysfunction (Mini-Mental State Examination Japanese version (MMSE-J) score <28) in Japan. Participants were randomly allocated to the green tea or placebo group, and consumed either 2 g/day of green tea powder (containing 220.2 mg of catechins) or placebo powder (containing 0.0 mg of catechins), respectively, for 12 months. Cognitive function assessments were performed every 3 months using the MMSE-J and laboratory tests.
Results: Thirty-three nursing home residents with cognitive dysfunction were enrolled (four men, 29 women; mean age ± SD, 84.8 ± 9.3; mean MMSE-J score ± SD, 15.8 ± 5.4), of whom 27 completed the study. Changes of MMSE-J score after 1 year of green tea consumption were not significantly different compared with that of the placebo group (-0.61 [-2.97, 1.74], least square mean (LSM) difference [95 % CI]; P = 0.59). However, levels of malondialdehyde-modified low-density lipoprotein (U/L), a marker of oxidative stress, was significantly lower in the green tea group (-22.93 [-44.13, -1.73], LSM difference [95 % CI]; P = 0.04).
Conclusions: Our results suggest that 12 months green tea consumption may not significantly affect cognitive function assessed by MMSE-J, but prevent an increase of oxidative stress in the elderly population. Additional long-term controlled studies are needed to clarify the effects.
Trial registration: UMIN000011668.
Keywords: Cognitive function; Elderly; Green tea; Oral administration; Randomized-controlled trial.
Similar articles
-
Green tea consumption affects cognitive dysfunction in the elderly: a pilot study.Nutrients. 2014 Sep 29;6(10):4032-42. doi: 10.3390/nu6104032. Nutrients. 2014. PMID: 25268837 Free PMC article.
-
Effect of Daily Intake of Green Tea Catechins on Cognitive Function in Middle-Aged and Older Subjects: A Randomized, Placebo-Controlled Study.Molecules. 2020 Sep 17;25(18):4265. doi: 10.3390/molecules25184265. Molecules. 2020. PMID: 32957612 Free PMC article.
-
Matcha consumption maintains attentional function following a mild acute psychological stress without affecting a feeling of fatigue: A randomized placebo-controlled study in young adults.Nutr Res. 2021 Apr;88:44-52. doi: 10.1016/j.nutres.2020.12.024. Epub 2021 Jan 2. Nutr Res. 2021. PMID: 33744591 Clinical Trial.
-
Green tea catechins: defensive role in cardiovascular disorders.Chin J Nat Med. 2013 Jul;11(4):345-53. doi: 10.1016/S1875-5364(13)60051-5. Chin J Nat Med. 2013. PMID: 23845542 Review.
-
Role of green tea catechins in prevention of age-related cognitive decline: Pharmacological targets and clinical perspective.J Cell Physiol. 2019 Mar;234(3):2447-2459. doi: 10.1002/jcp.27289. Epub 2018 Sep 6. J Cell Physiol. 2019. PMID: 30187490 Review.
Cited by
-
Effects of epigallocatechin-3-gallate on systemic inflammation-induced cognitive dysfunction in aged rats.J Anesth. 2017 Oct;31(5):726-735. doi: 10.1007/s00540-017-2392-5. Epub 2017 Jul 27. J Anesth. 2017. PMID: 28752431
-
Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders.Nutrients. 2021 Jun 29;13(7):2232. doi: 10.3390/nu13072232. Nutrients. 2021. PMID: 34209677 Free PMC article. Review.
-
Effects of a Raisin Supplement on Cognitive Performance, Quality of Life, and Functional Activities in Healthy Older Adults-Randomized Clinical Trial.Nutrients. 2023 Jun 20;15(12):2811. doi: 10.3390/nu15122811. Nutrients. 2023. PMID: 37375715 Free PMC article. Clinical Trial.
-
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022. Physiol Rev. 2024. PMID: 37843394 Free PMC article. Review.
-
Oral administration of encapsulated catechin in chitosan-alginate nanoparticles improves cognitive function and neurodegeneration in an aluminum chloride-induced rat model of Alzheimer's disease.Physiol Rep. 2024 Jul;12(13):e16095. doi: 10.14814/phy2.16095. Physiol Rep. 2024. PMID: 38946616 Free PMC article.
References
-
- Prince M, Guerchet M, Prina M. Alzheimer’s disease international. Policy brief for heads of government: The global impact of dementia 2013–2050. London: Alzheimer’s Disease International; 2013. https://www.alz.co.uk/research/GlobalImpactDementia2013.pdf. Accessed 27 Apr 2016.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases